4.8 Review

Antibiotic allergy

期刊

LANCET
卷 393, 期 10167, 页码 183-198

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(18)32218-9

关键词

-

资金

  1. National Institutes of Health, USA
  2. American Academy of Allergy, Asthma and Immunology Foundation, USA
  3. National Institutes of Health, USA [K43 TW011178-01, 1P50GM115305-01, 1P30AI110527-01A1, R21AI139021, R34AI136815]
  4. National Health and Medical Research Council (NHMRC) of Australia Early Careers Fellowship
  5. National Centre for Infections in Cancer (NCIC, Australia)
  6. NHMRC of Australia
  7. Australian Centre for HIV and Hepatitis Virology Research

向作者/读者索取更多资源

Antibiotics are the commonest cause of life-threatening immune-mediated drug reactions that are considered off-target, including anaphylaxis, and organ-specific and severe cutaneous adverse reactions. However, many antibiotic reactions documented as allergies were unknown or not remembered by the patient, cutaneous reactions unrelated to drug hypersensitivity, drug-infection interactions, or drug intolerances. Although such reactions pose negligible risk to patients, they currently represent a global threat to public health. Antibiotic allergy labels result in displacement of first-line therapies for antibiotic prophylaxis and treatment. A penicillin allergy label, in particular, is associated with increased use of broad-spectrum and non-beta-lactam antibiotics, which results in increased adverse events and antibiotic resistance. Most patients labelled as allergic to penicillins are not allergic when appropriately stratified for risk, tested, and re-challenged. Given the public health importance of penicillin allergy, this Review provides a global update on antibiotic allergy epidemiology, classification, mechanisms, and management.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据